scholarly article | Q13442814 |
P50 | author | Nicolas Wentzensen | Q28360639 |
Lori E. Dodd | Q37243588 | ||
Mark Schiffman | Q69142146 | ||
Cosette M Wheeler | Q87723651 | ||
Martha Nason | Q91593716 | ||
New Mexico HPV Pap Registry Steering Committee | Q114374087 | ||
P2093 | author name string | William C Hunt | |
P2860 | cites work | One virus, one lesion--individual components of CIN lesions contain a specific HPV type | Q34086371 |
Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. | Q34196510 | ||
Hierarchical Clustering of Human Papilloma Virus Genotype Patterns in the ASCUS-LSIL Triage Study | Q34268415 | ||
Human papillomavirus testing in the prevention of cervical cancer | Q34616083 | ||
Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease | Q34743370 | ||
Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women | Q34959801 | ||
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study | Q35164373 | ||
Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer | Q35223393 | ||
The epidemiology of genital human papillomavirus infection | Q36365671 | ||
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States | Q37147012 | ||
A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination | Q37366649 | ||
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants | Q37371137 | ||
The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period | Q40276124 | ||
Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses | Q44894609 | ||
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. | Q53340958 | ||
Human papillomavirus infections with multiple types and risk of cervical neoplasia. | Q53612097 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 855-864 | |
P577 | publication date | 2013-10-31 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study | |
P478 | volume | 209 |
Q35671337 | A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil |
Q44863515 | Carcinogenic human papillomavirus infection |
Q35907151 | Detection of Human Papillomavirus Infections at the Single-Cell Level |
Q40101782 | High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population |
Q92127918 | Human papillomavirus genotypes and P16INK4A expression in squamous penile carcinoma in Mexican patients |
Q42209167 | Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer |
Q34974475 | Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination |
Q40046605 | Oncogenic human papillomaviruses |
Q35166924 | Papillomaviruses: Viral evolution, cancer and evolutionary medicine |
Q36675963 | Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. |
Q38597567 | Prophylactic HPV vaccination: past, present, and future |
Q43924111 | Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline |
Q36165724 | Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta |
Search more.